Angene Chemical
Draw
|
Currency :
Home Products

AG003SYZ

114-80-7 | Neostigmine Bromide

Chemical structure of Neostigmine Bromide, CAS 114-80-7
AG003SYZ
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 114-80-7
Catalog Number AG003SYZ(AGN-PC-0P6SQA)
Chemical Name Neostigmine Bromide
EC Number 204-054-8
IUPAC Name [3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium;bromide
InChI InChI=1S/C12H19N2O2.BrH/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5;/h6-9H,1-5H3;1H/q+1;/p-1
InChI Key LULNWZDBKTWDGK-UHFFFAOYSA-M
MDL Number MFCD00011795
Molecular Formula C12H19BrN2O2
Molecular Weight 303.1955
NSC Number 757233
RTECS Number BR3150000
SMILES [Br-].O(C(=O)N(C)C)c1cc([N+](C)(C)C)ccc1
UNII 005SYP50G5
Synonyms
Bromide, Neostigmine, Methylsulfate, Neostigmine, Neostigmine, Neostigmine Bromide, Neostigmine Methylsulfate, Polstigmine, Proserine, Prostigmin, Prostigmine, Prozerin, Synstigmin, Syntostigmine, neostigmine bromide, 114-80-7, Eustigmin bromide, Neoserine bromide, Prostigmin, neo-Proserin, Proserine bromide, Stigmanol bromide, Synstigmin bromide, Leostigmine bromide, Kirkstigmine bromide, Philostigmin bromide, Vagostigmin, Stigmosan bromide, Prostigmin bromide, Neostigmine methyl bromide, Prostigmine bromide, Neostigmini bromidum, Synstigmini bromidum, Syntostigmin bromide, Vagostigmine bromide, 3-((Dimethylcarbamoyl)oxy)-N,N,N-trimethylbenzenaminium bromide, Syntostigmine bromide, Synthostigmine bromide, Syntostigmin (tablet), Bromure de neostigmine, Bromuro de neostigmina, Neostigmine (Bromide), Neostigmina bromuro [DCIT], Prostigmine, UNII-005SYP50G5, Neostigmini bromidum [INN-Latin], 3-[(dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium bromide, EINECS 204-054-8, Bromure de neostigmine [INN-French], Bromuro de neostigmina [INN-Spanish], 3-Dimethylcarbamoxyphenyl trimethyl ammonium bromide, MLS000028387, (m-Hydroxyphenyl)trimethylammonium bromide dimethylcarbamate, 3-Hydroxyphenyltrimethylammonium bromide dimethylcarbamic ester, CHEBI:179557, 005SYP50G5, MFCD00011795, AK162162, SMR000058591, Carbamic acid, dimethyl-, ester with (m-hydroxyphenyl)trimethylammonium bromide, DSSTox_CID_21075, DSSTox_RID_79621, DSSTox_GSID_41075, W-108598, 3-(Dimethylcarbamoyloxy)trimethylanilinium ion Bromatum, [3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium;bromide, Synstigminbromid, 3-(N,N-Dimethylcarbamoyloxy)-N,N,N,-trimethylanilinium bromide, 3-[[(Dimethylamino)carbonyl]oxy]-N,N,N-trimethylbenzenaminium bromide, AMMONIUM, (m-HYDROXYPHENYL)TRIMETHYL-, BROMIDE, DIMETHYLCARBAMATE, Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-, bromide, Benzenaminium, 3-[[(dimethylamino)carbonyl]oxy]-N,N,N-trimethyl-, bromide, Neostigmina bromuro, SR-01000000073, NCGC00163240-01, CAS-114-80-7, stigmanolbromide, stigmosanbromide, Neo proserine, C12H19N2O2.Br, synstigminbromide, syntostigminbromide, vagostigminebromide, syntostigminebromide, Vagostigmin (TN), synthostigminebromide, Prestwick_352, syntostigmin(tablet), Neostigmine bromide [INN:BAN:JAN], Prostigmin;Vagostigmin, Neostigmine bromide [USP:INN:BAN:JAN], AC1L1QKY, Opera_ID_1504, NEOSTIGIMINE BROMIDE, AC1Q1RH0, SCHEMBL41128, MLS001146913, CHEMBL54126, SPECTRUM1500428, Neostigmine-bromide(Prostigmin), DTXSID9041075, Neostigmine bromide (Prostigmin), HMS500I07, KS-00000YWF, HMS1569M18, HMS1920P15, HMS2091H18, HMS2096M18, HMS2235J11, HMS3262D13, HMS3372E02, HMS3713M18, Pharmakon1600-01500428, Eustigmin bromide;Neoserine bromide, ACT05638, HY-B0423, Neostigmine bromide (JAN/USP/INN), Tox21_112037, Tox21_500816, AN-333, BG0265, CCG-39110, GK7491, NSC757233, s2490, AKOS015895725, Tox21_112037_1, API0003538, CS-2529, LP00816, MCULE-9726153183, NSC-757233, NCGC00015730-11, NCGC00094149-01, NCGC00094149-02, NCGC00094149-03, NCGC00094149-04, NCGC00261501-01, LS-18446, Q562, SC-19050, MLS-0002855.P042, AB0004770, AB2000595, AX8144170, EU-0100816, FT-0083763, FT-0651572, N0358, ST24041334, ST50411544, C08197, D00995, N 2001, A803245, SR-01000000073-3, SR-01000000073-5, SR-01000000073-7, (3-Dimethylcarbamoyloxyphenyl)trimethylammonium Bromide, [3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium bromide, (m-Hydroxyphenyl)trimethyl-ammonium bromide dimethylcarbamate, [3-(dimethylcarbamoyloxy)phenyl]-trimethyl-ammonium bromide, N,N-dimethyl[3-(trimethylamino)phenoxy]carboxamide, bromide, Neostigmine bromide, >=98% (HPLC and titration), powder, (3-Hydroxyphenyl)trimethylammonium Bromide Dimethyl Carbamate, [3-[dimethylamino(oxo)methoxy]phenyl]-trimethylammonium bromide, Neostigmine bromide, European Pharmacopoeia (EP) Reference Standard, Neostigmine bromide, United States Pharmacopeia (USP) Reference Standard, bromide, NEOSTIGMINE, RCRA waste number U053, C12H19BrN2O2, CID8246, C12-H19-N2-O2.Br, Neostigmine bromide [BAN:INN:JAN], AR-1F0755, B1594, A10635, [3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium bromide, Neostigmine bromide, 98%, a reversible acetylcholinesterase inhibitor - 1G 1g, 61-70-1,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited